DK0410278T3 - Pure inhibiting amino oligohydroxy derivatives - Google Patents

Pure inhibiting amino oligohydroxy derivatives

Info

Publication number
DK0410278T3
DK0410278T3 DK90113712.5T DK90113712T DK0410278T3 DK 0410278 T3 DK0410278 T3 DK 0410278T3 DK 90113712 T DK90113712 T DK 90113712T DK 0410278 T3 DK0410278 T3 DK 0410278T3
Authority
DK
Denmark
Prior art keywords
oligohydroxy
derivatives
pure
inhibiting amino
inhibiting
Prior art date
Application number
DK90113712.5T
Other languages
Danish (da)
Inventor
Hansjoerg Dr Urbach
Adalbert Dr Wagner
Heinz-Werner Dr Kleemann
Dieter Dr Ruppert
Wolfgang Dr Linz
Werner Dr Dr Kramer
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE3924506A external-priority patent/DE3924506A1/en
Priority claimed from DE19893932817 external-priority patent/DE3932817A1/en
Application filed by Hoechst Ag filed Critical Hoechst Ag
Application granted granted Critical
Publication of DK0410278T3 publication Critical patent/DK0410278T3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Saccharide Compounds (AREA)
  • Solid Fuels And Fuel-Associated Substances (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)
  • Footwear And Its Accessory, Manufacturing Method And Apparatuses (AREA)
  • Hydrogenated Pyridines (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)

Abstract

The present invention relates to compounds of the formula I <IMAGE> in which A, R<2>, R<3>, R<4> and n are defined as indicated in the description, to processes for the preparation thereof, to the use thereof as medicines and to pharmaceutical compositions containing these.
DK90113712.5T 1989-07-25 1990-07-18 Pure inhibiting amino oligohydroxy derivatives DK0410278T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3924506A DE3924506A1 (en) 1989-07-25 1989-07-25 New poly:hydroxy:amide derivs.
DE19893932817 DE3932817A1 (en) 1989-09-30 1989-09-30 New poly:hydroxy:amide derivs.

Publications (1)

Publication Number Publication Date
DK0410278T3 true DK0410278T3 (en) 1994-05-24

Family

ID=25883333

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90113712.5T DK0410278T3 (en) 1989-07-25 1990-07-18 Pure inhibiting amino oligohydroxy derivatives

Country Status (20)

Country Link
EP (1) EP0410278B1 (en)
JP (1) JPH0366652A (en)
KR (1) KR910002776A (en)
CN (1) CN1049164A (en)
AT (1) ATE100463T1 (en)
AU (1) AU639246B2 (en)
CA (1) CA2021822A1 (en)
CS (1) CS368890A3 (en)
DE (1) DE59004292D1 (en)
DK (1) DK0410278T3 (en)
ES (1) ES2062214T3 (en)
FI (1) FI903701A0 (en)
HU (1) HU205140B (en)
IE (1) IE902686A1 (en)
IL (1) IL95166A0 (en)
MA (1) MA21913A1 (en)
NO (1) NO903291L (en)
NZ (1) NZ234608A (en)
PL (1) PL286188A1 (en)
PT (1) PT94798A (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW209870B (en) * 1990-01-18 1993-07-21 Pfizer
IE68045B1 (en) * 1990-05-11 1996-05-15 Abbott Lab Renin inhibitors
WO1992003472A1 (en) * 1990-08-24 1992-03-05 The Upjohn Company Peptides containing amino-polyols as transition-state mimics
EP0483403A1 (en) * 1990-10-31 1992-05-06 Hoechst Aktiengesellschaft Derivatives of amino acids as inhibitors of renin, methods for their preparation, medicaments containing them and their use
CA2404644A1 (en) * 2000-04-10 2001-10-18 Yuichi Ishida Modulators of prorenin activity

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK34086A (en) * 1985-01-23 1986-07-24 Abbott Lab PEPTIDYLAMINODIOLS
NZ218937A (en) * 1986-01-16 1990-03-27 Abbott Lab Functionalised peptidyl aminodiols and -triols as renin inhibitors and pharmaceutical compositions
US4863905A (en) * 1987-02-04 1989-09-05 Warner-Lambert Company Renin inhibitors II

Also Published As

Publication number Publication date
EP0410278B1 (en) 1994-01-19
KR910002776A (en) 1991-02-26
NZ234608A (en) 1991-12-23
DE59004292D1 (en) 1994-03-03
NO903291L (en) 1991-01-28
NO903291D0 (en) 1990-07-24
IL95166A0 (en) 1991-06-10
ES2062214T3 (en) 1994-12-16
FI903701A0 (en) 1990-07-23
HU205140B (en) 1992-03-30
JPH0366652A (en) 1991-03-22
MA21913A1 (en) 1991-04-01
HU904582D0 (en) 1990-12-28
IE902686A1 (en) 1991-02-27
EP0410278A1 (en) 1991-01-30
AU5971990A (en) 1991-01-31
ATE100463T1 (en) 1994-02-15
HUT55033A (en) 1991-04-29
CN1049164A (en) 1991-02-13
CA2021822A1 (en) 1991-01-26
PT94798A (en) 1991-03-20
PL286188A1 (en) 1991-04-22
CS368890A3 (en) 1992-02-19
AU639246B2 (en) 1993-07-22

Similar Documents

Publication Publication Date Title
GR3018212T3 (en) Naphtylalkylamines, process for their preparation and pharmaceutical compositions containing them.
IL101819A0 (en) Amidinophenylalanine derivatives,a process for the preparation thereof,use thereof and agents containing these as anticoagulants
DK0580502T3 (en) 3- (hydroxybenzylidenyl) -indolin-2-ones and pharmaceutical compositions containing them
IL90912A0 (en) Condensed heterocyclic compounds,their manufacture and pharmaceutical compositions containing them
ZA926328B (en) Naphthylethylureas and naphthylethylthioureas process for the preparation thereof and pharmaceutical compositions containing them.
GR3029406T3 (en) Pyridothiadiazines, processes for their preparation and pharmaceutical compositions containing them.
IL102759A0 (en) Hydantoin derivatives,their preparation and pharmaceutical compositions containing them
ZA936658B (en) Benzopyran compounds process for their preparation and the pharmaceutical compositions which contain them
DE69312984T2 (en) Substituted aminophosphonate derivatives, processes for their preparation and pharmaceutical compositions containing them
DK0564358T3 (en) 3-Aminochroman Spiro Derivatives, Methods of Preparation thereof and Pharmaceutical Compositions Containing Such
DK0410278T3 (en) Pure inhibiting amino oligohydroxy derivatives
ZA933455B (en) Thiochroman compounds, processes for the preparation thereof and pharmaceutical compositions containing them
ZA935277B (en) Aminoalkylchromones processes for the preparation thereof and pharmaceutical compositions containing them
ZA941196B (en) Angiopeptin cyclopeptide compounds process for the preparation thereof and pharmaceutical compositions containing them
DK0418990T3 (en) 13-bromo- and 13,14-dibromo-ergolines, their preparation and use in pharmaceuticals
IL104444A0 (en) Alpha-aryl-alpha-hydroxy-beta-imidazolinyl-propionamides,their preparation and pharmaceutical compositions containing them
ZA933942B (en) Pyrrolothienopyrazine compounds, processes for the preparation thereof and pharmaceutical compositions containing them
ZA941056B (en) (Cyclohexyl)alkene compounds processes for preparing them and pharmaceutical compositions containing them
DK0635491T3 (en) (Thia) cycloalkylab indoles, processes for their preparation and pharmaceutical compositions containing these compounds.